New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Tasmanian Alkaloids calls for legalisation of cannabidiolon January 22, 2020 at 5:27 pm
Tasmanian Alkaloids has called on the federal government to relax controls over cannabidiol (CBD) - a non-psychoactive chemical found in cannabis plants. A Senate inquiry was established last year to ...
- Brazil Facilitates Import Of Medicines Derived From Marijuanaon January 22, 2020 at 4:02 pm
RIO DE JANEIRO – The Brazilian government announced on Wednesday a series of measures to facilitate the import of medicines based on cannabidiol, one of the active ingredients in marijuana. The move ...
- 3 CBD Stocks to Benefit From Passage of a CBD Billon January 22, 2020 at 11:06 am
While the U.S. Federal government doesn’t appear any closer to approving cannabis, Congress does appear set to tackle the regulations holding back widescale sales of cannabidiol or CBD. The passage of ...
- Algoma CBD business expands with large-capacity hemp extractoron January 22, 2020 at 10:51 am
Native Roots Hemp's new machine can process 1,000 pounds of hemp a day, part of a plan that includes finding uses for hemp biomass after extraction.
- Global Cannabidiol Oil (CBD Oil) 2020 Industry Trends, Sales, Supply, Demand, Analysis & Forecast to 2026on January 22, 2020 at 7:07 am
New Study Reports "Cannabidiol Oil (CBD Oil) Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports. This report provides in depth study ...
- CBD for Pain Management: The Holistic Alternative to Opioidson January 21, 2020 at 4:31 pm
You worry about becoming addicted, but you aren't sure what else to try. People like you are turning to Cannabidiol (CBD), a holistic alternative to opioids. While opioids are known to be highly ...
- Medicinal Cannabis May Not Help with Sleep in the Long Runon January 21, 2020 at 4:21 pm
So far, research on the sleep benefits of cannabis — or cannabis compounds like tetrahydrocannabinol (THC) and cannabidiol (CBD) — has been mixed. Also, while some studies have shown positive effects, ...
- Global Cannabidiol Oil (CBD) Supplements Market 2020 Demand, Market Size, Share, Product Analysis, Regional Outlook and Forecast-2026on January 21, 2020 at 8:40 am
Supplements Market” WiseGuyRerports.com Presents "Global Cannabidiol Oil (CBD) Supplements Market Research Report 2020" New Document to ...
- Study: Cannabidiol may not ease sleep problems, especially for regular userson January 20, 2020 at 8:32 pm
(CNN) — If the weed Twitterverse is to be believed, a lot of marijuana users rely on a nightly puff or two to drift off into la-la land. And surveys of marijuana users show they do indeed rely on the ...
- Cannabidiol (CBD) Cosmetics Global Market Size, Share, Demand, Growth, Opportunities, Analysis of Top Key Player and Forecast to 2026on January 16, 2020 at 9:35 pm
Cosmetics” This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market ...
via Bing News